1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Insulin Sensitivity Test: new trials by email Literature Review of Insulin Sensitivity Test trials Research Report on Insulin Sensitivity Test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway Vericiguat 10 MG, Placebo, Insulin Sensitivity Test - Cardiovascular Diseases, Insulin Sensitivity/Resistance | Phase 2 | Not yet recruiting | University of Alabama at Birmingham | 200 | 2026-12-01 | 2026-01-23 |
| Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 Adipose Tissue Biopsy, Steady State Plasma Glucose (SSPG) Test - Long COVID, Insulin Resistance | Not applicable | Recruiting | Stanford University | 55 | 2023-06-06 | 2024-12-04 |
Insulin Resistance (2) · Cardiovascular Diseases (1) · Metabolic Diseases (1) · Obesity (1) · Post-Acute COVID-19 Syndrome (1)
Stanford University (1) · University of Alabama at Birmingham (1)
United States (2)
Pankaj Arora, MD, FAHA (1) · Tracey McLaughlin, MD (1)